Follow The Filings

PTHS Pelthos Therapeutics

Pelthos Therapeutics earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -6.62 —
Rev — $15.6M —

Insider trades

Open-market buys and sales by PTHS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PTHS insider trades
  • $1M bought by 1 insider
  • $321K sold by 2 insiders outside a trading plan
  • $166K sold by 4 insiders under 10b5-1 plans
  1. Peter Greenleaf Director
    Planned sale
    $17K 797 shares at $21.17 3.3% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  2. Ezra M Friedberg Director
    Planned sale
    $12K 558 shares at $20.72 0.7% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  3. Matthew Pauls Director
    Planned sale
    $17K 786 shares at $21.00 5.5% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  4. Ezra M Friedberg Director
    Planned sale
    $15K 558 shares at $26.09 0.7% of stake
    Traded Jul 2 Filed Jul 7
    ↗
  5. Matthew Pauls Director
    Planned sale
    $21K 786 shares at $26.16 5.2% of stake
    Traded Jul 2 Filed Jul 7
    ↗
  6. Peter Greenleaf Director
    Planned sale
    $21K 797 shares at $26.13 3.2% of stake
    Traded Jul 2 Filed Jul 7
    ↗
  7. Ezra M Friedberg Director
    Planned sale
    $7,724 283 shares at $27.29 0.3% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  8. Todd C Davis Director
    Buy
    $1M 35,948 shares at $27.82 +90% to stake
    Traded Jun 11 Filed Jun 15
    ↗
  9. Knuettel Francis II CFO
    Sale
    $40K 1,500 shares at $26.84 12% of stake
    Traded May 22 Filed May 26
    ↗
  10. Richard Malamut Director
    Planned sale
    $12K 590 shares at $20.92 2.1% of stake
    Traded Apr 2 Filed Apr 6
    ↗
  11. Ezra M Friedberg Director
    Planned sale
    $12K 558 shares at $20.92 0.7% of stake
    Traded Apr 2 Filed Apr 6
    ↗
  12. Matthew Pauls Director
    Planned sale
    $16K 786 shares at $20.92 4.9% of stake
    Traded Apr 2 Filed Apr 6
    ↗
  13. Peter Greenleaf Director
    Planned sale
    $17K 797 shares at $20.92 3.1% of stake
    Traded Apr 2 Filed Apr 6
    ↗
  14. Ezra M Friedberg Director
    Sale
    $280K 10,000 shares at $28.03 25% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 2 stock grants, 1 sale back to the company, 1 share withholding for taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 5.02,5.07,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 4.02 Filing Doc
10-Q/A Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 4.01,5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.